August 29, 2012
Mitsubishi Tanabe Pharma Corporation (MTPC) and Daiichi Sankyo announced on August 28 that they will launch the DPP-4 (dipeptidly peptidase-4) inhibitor Tenelia 20 mg Tablet (teneligliptin hydrobromide hydrate) in Japan on September 10. The two companies will comarket the product...read more